Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

for
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer,
Location: Boston MA, New York NY, Houston TX, San Antonio TX,
Sponsor: Monopteros Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04859777

Phase 1, Recruiting

Improving Health Insurance Literacy Among Young Adult Cancer Survivors

for
Cancer
Location: Salt Lake City UT, Murray UT
Sponsor: University of Utah

Sex: All

Age: 26 - 45

Code: NCT05829070

Recruiting

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

for
Solid Tumours
Location: Valhalla NY, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Orion Corporation, Orion Pharma

Sex: All

Age: 18+

Code: NCT06725758

Phase 1, Phase 2, Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

for
Castration-Resistant Prostate Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693377

Recruiting

Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06562777

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

for
Locally Advanced Cancer, Metastatic Cancer, HER2,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06828588

Early Phase 1, Recruiting

Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors

for
Metastatic Solid Tumor, Locally Advanced Solid Tumor
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06358677

Phase 2, Recruiting

RAPA-201 Therapy of Solid Tumors

for
Solid Tumor, Small Cell and Non-small Cell Lung Cancer,
Location: Hackensack NJ
Sponsor: Rapa Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05144698

Phase 1, Phase 2, Recruiting

Adapting the Tumor Board Model for Mental Illness and Cancer

for
Cancer, Severe Major Depression, Schizophrenia,
Location: Danvers MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05837598

Recruiting

Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Houston TX
Sponsor: Purinomia Biotech, Inc.

Sex: All

Age: 18+

Code: NCT05234853

Phase 1, Recruiting

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, The Bronx NY, Baltimore MD, Miami FL,
Sponsor: DynamiCure Biotechnology

Sex: All

Age: 18+

Code: NCT05785754

Phase 1, Recruiting

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

for
Solid Tumors, Adult
Location: Plantation FL, Cleveland OH, Denver CO
Sponsor: Hutchmed

Sex: All

Age: 18+

Code: NCT07228247

Phase 1, Phase 2, Recruiting

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

for
Recurrent Glioblastoma,
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT07416188

Phase 1, Phase 2, Recruiting

Feasibility of Hyivy Device Post-Radiation for Pelvic Malignancies

for
Vaginal Stenosis, Radiation Therapy, Cancer, Pelvic Pain,
Location: Kitchener
Sponsor: Hyivy Health Inc

Sex: Female

Age: 18+

Code: NCT05648253

Recruiting

EUS BD vs ERCP TP for Pancreatic Cancer

for
Pancreatic Cancer, Pancreatic Adenocarcinoma,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70+

Code: NCT03063554

Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: Providence RI, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer,
Location: New York NY, Huntersville NC
Sponsor: GI Innovation, Inc.

Sex: All

Age: 18+

Code: NCT04977453

Phase 1, Phase 2, Recruiting

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

for
Cancer, Dementia
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 65+

Code: NCT06313853

Recruiting

Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study

for
Cancer, Immunotherapy, Fatigue Related to Cancer Treatment,
Location: Orange CA, Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT07581080

Recruiting

Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors

for
Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 65+

Code: NCT07390045

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial